Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 111.80
-0.10 (-0.09%)
Nov 19, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 102.98 billion as of November 19, 2025. Its market cap has increased by 66.41% in one year.
Market Cap
102.98B
Enterprise Value
100.05B
Revenue
2.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
111.80
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 102.98B, an increase of 455.34%. That is a compound annual growth rate of 36.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 103.08B | 89.19% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 313.45B |
| Hansoh Pharmaceutical Group Company | 236.23B |
| JD Health International | 214.82B |
| Innovent Biologics | 154.92B |
| WuXi Biologics | 130.87B |
| Sino Biopharmaceutical | 124.78B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.34B |
| Alibaba Health Information Technology | 93.14B |